全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Staphylococcus lugdunensis Endocarditis Complicated by Embolism in an 18-Year-Old Woman with Mitral Valve Prolapse

DOI: 10.1155/2013/730924

Full-Text   Cite this paper   Add to My Lib

Abstract:

Staphylococcus lugdunensis is a coagulase-negative staphylococcus (CNS). It is a major cause of prosthetic valve endocarditis; mitral valve prolapse (MVP) has emerged as a prominent predisposing structural cardiac abnormality. We describe a case of Staphylococcus lugdunensis endocarditis in an 18-year-old woman with preexisting mitral valve prolapse complaining of fever, a one-month history of continuous-remittent fever ( 38.6°C). The transthoracic echocardiogram revealed large vegetation on the anterior mitral valve leaflet flopping from the atrial side to the ventricular side. Five sets of blood cultures were positive for coagulase-negative staphylococci. During hospitalization, after two weeks of antibiotic therapy, the patient complained of sudden pain in her right leg associated with numbness. Lower limb arterial Doppler ultrasound showed an arterial thrombosis of right common iliac artery. Transfemoral iliac embolectomy was promptly performed and on septic embolus S. lugdunensis with the same antibiotic sensitivity and the same MIC values was again isolated. Our patient underwent cardiac surgery: triangular resection of the A2 with removal of infected tissue including vegetation. Our case is an example of infective endocarditis by S. lugdunensis on native mitral valve in a young woman of 18 with anamnesis valve prolapse. 1. Introduction Staphylococcus lugdunensis is a coagulase-negative staphylococcus (CNS). It is a major cause of prosthetic valve endocarditis, particularly during the initial years after valve surgery, an important cause of nosocomial infective endocarditis (IE) and the cause of 3 to 8 percent of native valve endocarditis, usually in the setting of prior valve abnormalities; among these, mitral valve prolapse (MVP) has emerged as a prominent predisposing structural cardiac abnormality [1]. S. lugdunensis, which was first described in 1988 [2], was distinguished from other coagulase-negative staphylococcal species via DNA relatedness studies based on 11 clinical strains. Like other CNS, S. lugdunensis in humans ranges from a harmless skin commensal to a life-threatening pathogen (as with infective endocarditis) but it is considered unique among CNS because of its propensity for causing aggressive native valve infective endocarditis (IE) often fatal and usually community acquired [3]. We describe a case of Staphylococcus lugdunensis endocarditis in an 18-year-old woman with preexisting mitral valve prolapse in order to emphasize the aggressiveness, as documented in the literature yet available, of this staphylococcus which takes on

References

[1]  J. T. M. van der Meer, J. Thompson, H. A. Valkenburg, and M. F. Michel, “Epidemiology of bacterial endocarditis in the Netherlands: I. Patient characteristics,” Archives of Internal Medicine, vol. 152, no. 9, pp. 1863–1868, 1992.
[2]  J. Freney, Y. Brun, M. Bes et al., “Staphylococcus lugdunensis sp. nov. and Staphylococcus schleiferi sp. nov., two species from human clinical specimens,” International Journal of Systematic Bacteriology, vol. 38, no. 2, pp. 168–172, 1988.
[3]  C. Whitener, G. M. Caputo, M. R. Weitekamp, and A. W. Karchmer, “Endocarditis due to coagulase-negative staphylococci: microbiologic, epidemiologic, and clinical considerations,” Infectious Disease Clinics of North America, vol. 7, no. 1, pp. 81–96, 1993.
[4]  J. S. Li, D. J. Sexton, N. Mick et al., “Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis,” Clinical Infectious Diseases, vol. 30, no. 4, pp. 633–638, 2000.
[5]  G. Habib, B. Hoen, P. Tornos et al., “Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009). The task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC) Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for infection and cancer,” European Heart Journal, vol. 30, no. 19, pp. 2369–2413, 2009.
[6]  R. O. Bonow, B. A. Carabello, K. Chatterjee, et al., “ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with valvular heart disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons,” Circulation, vol. 114, pp. e84–e231, 2006, Erratum in: Circulation, vol. 115, p. e409, 2007.
[7]  C. von Eiff, R. A. Proctor, and G. Peters, “Coagulase-negative staphylococci: pathogens have major role in nosocomial infections,” Postgraduate Medicine, vol. 110, no. 4, pp. 63-64, 69-70, 73–76, 2001.
[8]  T. E. Herchline and L. W. Ayers, “Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection,” Journal of Clinical Microbiology, vol. 29, no. 3, pp. 419–421, 1991.
[9]  C. A. Petti and V. G. Fowler Jr, “Staphylococcus aureus bacteremia and endocarditis,” Clinical Cardiology, vol. 21, pp. 219–233, 2003.
[10]  A. S. Zinkernagel, M. S. Zinkernagel, M. V. Elzi et al., “Significance of Staphylococcus lugdunensis bacteremia: report of 28 cases and review of the literature,” Infection, vol. 36, no. 4, pp. 314–321, 2008.
[11]  P. Y. Liu, Y. F. Huang, C. W. Tang et al., “Staphylococcus iugdunensis infective endocarditis: a literature review and analysis of risk factors,” Journal of Microbiology, Immunology and Infection, vol. 43, no. 6, pp. 478–484, 2010.
[12]  A. Renzulli, A. Delia Corte, M. Torella, G. Dialetto, and M. Cotrufo, “Mitral and aortic valve endocarditis: due to Staphylococcus lugdunensis,” Texas Heart Institute Journal, vol. 27, no. 1, pp. 67–69, 2000.
[13]  S. M. Kralovic, H. Melin-Aldana, K. K. Smith, and C. C. Linnemann Jr., “Staphylococcus lugdunensis endocarditis after tooth extraction,” Clinical Infectious Diseases, vol. 20, no. 3, pp. 715–716, 1995.
[14]  T. W. Koh, S. J. D. Brecker, and C. A. Layton, “Successful treatment of Staphylococcus lugdunensis endocarditis complicated by multiple emboli: a case report and review of the literature,” International Journal of Cardiology, vol. 55, no. 2, pp. 193–197, 1996.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133